Ibrahim Yakoub‐Agha

Author

Ibrahim Yakoub‐Agha

Centre Hospitalier Universitaire de Lille ORCID

Also Known As

David Beauvais, Didier Blaise, I YAKOUBAGHA, I YAKOUB‐AGHA, I Yacoub-Agha, I Yakoub Agha, I Yakoub-Agha, I. Y. Agha, I. Yakoub Agha, I. Yakoub-Agha

Publications

26.1K

Citations

H-Index

140

Concepts

All Affiliations

Centre Hospitalier Universitaire de Lille Inserm Université de Lille Sorbonne Université Hôpital Saint-Louis

About

Ibrahim Yakoub‐Agha is an author at Centre Hospitalier Universitaire de Lille specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	47	143	7.6K
2	Health Sciences	31	67	3.9K
3	Public Health	5	5	184
4	Law	1	1	13
5	Management	1	1	26

Ibrahim Yakoub‐Agha

286

Publications

20.4K

Citations

H-Index

Page 1

	Year	Citations
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma Nikhil C. Munshi, Larry D. Anderson, Nina Shah, New England Journal of Medicine	2021	2.3K
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome Hervé Avet‐Loiseau, Michel Attal, Philippe Moreau, Blood	2007	899
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial Thierry Façon, Jean Yves Mary, Cyrille Hulin, The Lancet Hematological MalignancyCell TherapyTransplantationMarrow TransplantationElderly Patients	2007	870
Maintenance therapy with thalidomide improves survival in patients with multiple myeloma Michel Attal, Jean‐Luc Harousseau, Serge Leyvraz, Blood	2006	667
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial Caron A. Jacobson, Julio C. Chávez, Alison R. Sehgal, The Lancet Oncology Lymphoid NeoplasiaAxicabtagene CiloleucelMedicinePathologyPharmacotherapy	2021	574
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation Mohamad Mohty, Florent Malard, Michaël Abécassis, Bone Marrow Transplantation	2016	511
Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years Jakob Passweg, Helen Baldomero, Christian Chabannon, Bone Marrow Transplantation	2021	397
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA) Patrick Hayden, Claire Roddie, Peter Bader, Annals of Oncology	2021	389
Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma Frédéric Garban, Michel Attal, Mauricette Michallet, Blood	2006	370
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) Ibrahim Yakoub‐Agha, Christian Chabannon, Peter Bader, Haematologica Cell TherapyImmunologyTransplantation MedicineCell Replacement TherapyImmunotherapeutics	2019	343

Page 1